𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson's disease?

✍ Scribed by Aline Gronchi-Perrin; Sarah Viollier; Joseph Ghika; Pierre Combremont; Jean-Guy Villemure; Julien Bogousslavsky; Pierre R. Burkhard; François Vingerhoets


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
62 KB
Volume
21
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

We investigated the impact of subthalamic nucleus (STN) deep brain stimulation (DBS) on quality of life (QOL) in patients with advanced Parkinson's disease, as self‐assessed before and after surgery by completing the Parkinson's Disease Questionnaire (PDQ39). In addition to this prospective evaluation, we asked patients postoperatively to evaluate their preoperative QOL. In the prospective assessment, results showed that patients perceived a general improvement of QOL after the STN DBS. However, when evaluated retrospectively, they tended to overestimate their preoperative functioning, therefore obscuring the improvement found prospectively. This observation highlights the impact of the method used on obtained results when assessing the effects of STN DBS. © 2006 Movement Disorder Society


📜 SIMILAR VOLUMES


Subthalamic nucleus deep brain stimulati
✍ Michelle R. Ciucci; Julie M. Barkmeier-Kraemer; Scott J. Sherman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

## Abstract Relatively little is known about the role of the basal ganglia in human deglutition. Deep brain stimulation (DBS) affords us a model for examining deglutition in humans with known impairment of the basal ganglia. The purpose of this study was to examine the effects of subthalamic nuclei

Deep brain stimulation of the subthalami
✍ Bruno Fimm; Ines A. Heber; Volker A. Coenen; Christoph Fromm; Johannes Noth; Mar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

## Abstract Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is a treatment option for patients with Parkinson's disease (PD) in the advanced stage. Besides motor improvement, DBS of the STN may also modulate cognitive and attentional functions of the basal ganglia. In our study, 13 pa

Functional imaging of subthalamic nucleu
✍ Tessel Boertien; Ludvic Zrinzo; Joshua Kahan; Marjan Jahanshahi; Marwan Hariz; L 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

Deep brain stimulation of the subthalamic nucleus is an accepted treatment for the motor complications of Parkinson's disease. The therapeutic mechanism of action remains incompletely understood. Although the results of deep brain stimulation are similar to the results that can be obtained by lesion

Addiction in Parkinson's disease: Impact
✍ Tatiana Witjas; Christelle Baunez; Jean Marc Henry; Marie Delfini; Jean Regis; A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 1 views

## Abstract In Parkinson's disease, dopamine dysregulation syndrome (DDS) is characterized by severe dopamine addiction and behavioral disorders such as manic psychosis, hypersexuality, pathological gambling, and mood swings. Here, we describe the case of 2 young parkinsonian patients suffering fro

Is improvement in the quality of life af
✍ Christine Daniels; Paul Krack; Jens Volkmann; Jan Raethjen; Markus O. Pinsker; M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 1 views

## Abstract Deep brain stimulation (DBS) of the subthalamic nucleus (STN) significantly improves quality of life (QoL) in PD. However, QoL fails to improve in a relevant proportion of patients. We studied clinical baseline and progression parameters associated with improvement in QoL after DBS. Dat

Bilateral subthalamic nucleus stimulatio
✍ Pablo Martínez-Martín; Francesc Valldeoriola; Eduardo Tolosa; Manuela Pilleri; J 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 1 views

## Abstract We examined the impact of the subthalamic nuclei (STN) deep brain stimulation (DBS) on the health‐related quality of life (QoL) of patients with advanced Parkinson's disease (PD). Seventeen consecutive patients with refractory motor fluctuations and dyskinesia were included in the study